Form D · Biotechnology
BioMedInnovations LLC
Denver, NC · CIK 0002019097
Offering snapshot reported Apr 10, 2024 · SEC filing
- Reported sold
- $100K Offering amount: $9M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Mar 17, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 10, 2024 | Initial | $100,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-510203
Source: Form D, filed Apr 10, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| George Barr | Director |
| Carrie Di Marzio | Director, Executive |
| Elizabeth Flanary | Director |
| David Gerber | Executive |
| Robert Neusner | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
771 Crosspoint Drive
Denver, NC, 28037
Denver, NC, 28037